ORIGINAL RESEARCH
Accepted on 30 Dec 2025
A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice
- 113 views
1,140
Total downloads
10k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
ORIGINAL RESEARCH
Accepted on 30 Dec 2025
REVIEW
Published on 04 Nov 2025
ORIGINAL RESEARCH
Published on 30 May 2025
ORIGINAL RESEARCH
Published on 29 May 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.